In states of chronic systemic hyperinsulinemia, the loss of responsiveness to insulin-targeting of apoB for degradation together with increased fatty acid flux to the liver, and increased DNL, results in increased VLDL secretion ( 34 ). The gene discussed is INS; the disease is hyperinsulinism.